Could a blood pressure drug help fight melanoma?

NCT ID NCT01009177

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial tested whether adding bosentan, a drug used for blood vessel conditions, to standard chemotherapy (dacarbazine) could slow tumor growth in people with stage IV melanoma. The study enrolled 80 adults with advanced melanoma and compared the combination to chemotherapy alone. The main goal was to see how long patients lived without their cancer getting worse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bosentan
What this could lead to
If successful, this could point toward a new combination treatment to slow tumor growth in advanced melanoma.
What could go wrong
This is an early Phase 2 trial with only 80 participants, so results may not be conclusive. Bosentan is already used for other conditions and may not improve outcomes in melanoma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barwon Health - The Geelong Hospital

    Geelong, VIC 3220, Australia

  • Cabrini Hopsital - Oncology Department

    Malvern, VIC 2144, Australia

  • Mater Adult Hospital

    South Brisbane, QLD 4001, Australia

  • Mount Medical Centre

    Perth, WA, Australia

  • New Castle Melanoma Unit

    Newcastle, NSW, Australia

  • Pacific Private Clinic

    Southport, QLD 4215, Australia

  • Redcliffe Hospital - Dept Oncology & Palliative Care

    Redcliffe, QLD 4020, Australia

  • Royal North Shore Hospital

    St Leonards, NSW, Australia

  • Southern Medical Day Care Centre

    Wollongong, NSW, Australia

  • Sydney Cancer Centre, Royal Prince Alfred Hospital

    Sydney, NSW, Australia

  • Sydney Haematology and Oncology Unit

    Hornsby, NSW, Australia

  • Westmead Hospital - Department of Oncology

    Westmead, NSW 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.